2012, ISBN: 9782817803357
[ED: Hardcover], [PU: Springer / Springer Paris / Springer, Berlin], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but als… Meer...
booklooker.de buecher.de GmbH & Co. KG Verzendingskosten:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) Details... |
Biosimilars | A New Generation of Biologics | Jean-Louis Prugnaud (u. a.) | Buch | Englisch | 2012 | Springer Paris | EAN 9782817803357 - gebonden uitgave, pocketboek
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Meer...
booklooker.de |
Biosimilars / A New Generation of Biologics / Jean-Louis Prugnaud (u. a.) / Buch / Englisch / 2012 / Springer Paris / EAN 9782817803357 - gebonden uitgave, pocketboek
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Meer...
booklooker.de |
Biosimilars A New Generation of Biologics Jean-Louis Prugnaud (u. a.) Buch Englisch 2012 Springer Paris EAN 9782817803357 - gebonden uitgave, pocketboek
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Meer...
booklooker.de |
2013, ISBN: 2817803353
Gebundene Ausgabe Arznei - Arzneimittel, Medikament, Pharmaka, Tablette, Immunsystem - Immunologie - Immun - Autoimmunität, Krebs (Krankheit) / Onkologie, Onkologie - Radioonkologie, Med… Meer...
Achtung-Buecher.de MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien Verzendingskosten:Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803357
[ED: Hardcover], [PU: Springer / Springer Paris / Springer, Berlin], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but als… Meer...
Prugnaud, Jean-Louis:
Biosimilars | A New Generation of Biologics | Jean-Louis Prugnaud (u. a.) | Buch | Englisch | 2012 | Springer Paris | EAN 9782817803357 - gebonden uitgave, pocketboek2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Meer...
Biosimilars / A New Generation of Biologics / Jean-Louis Prugnaud (u. a.) / Buch / Englisch / 2012 / Springer Paris / EAN 9782817803357 - gebonden uitgave, pocketboek
2012
ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Meer...
Biosimilars A New Generation of Biologics Jean-Louis Prugnaud (u. a.) Buch Englisch 2012 Springer Paris EAN 9782817803357 - gebonden uitgave, pocketboek
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Meer...
2013, ISBN: 2817803353
Gebundene Ausgabe Arznei - Arzneimittel, Medikament, Pharmaka, Tablette, Immunsystem - Immunologie - Immun - Autoimmunität, Krebs (Krankheit) / Onkologie, Onkologie - Radioonkologie, Med… Meer...
Bibliografische gegevens van het best passende boek
auteur: | |
Titel: | |
ISBN: |
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities.
In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature.
This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the Eu
Gedetalleerde informatie over het boek. - Biosimilars
EAN (ISBN-13): 9782817803357
ISBN (ISBN-10): 2817803353
Gebonden uitgave
Verschijningsjaar: 20121130
Uitgever: Springer Editions
87 Bladzijden
Gewicht: 0,343 kg
Taal: Englisch
Boek bevindt zich in het datenbestand sinds 2007-02-10T18:10:29+01:00 (Amsterdam)
Detailpagina laatst gewijzigd op 2022-08-19T11:29:49+02:00 (Amsterdam)
ISBN/EAN: 2817803353
ISBN - alternatieve schrijfwijzen:
2-8178-0335-3, 978-2-8178-0335-7
alternatieve schrijfwijzen en verwante zoekwoorden:
Auteur van het boek: jean hugues, john seymour, louis
Titel van het boek: leben auf dem lande
Gegevens van de uitgever
Auteur: Jean-Louis Prugnaud; Jean-Hugues Trouvin
Titel: Biosimilars - A New Generation of Biologics
Uitgeverij: Springer; Springer Paris
90 Bladzijden
Verschijningsjaar: 2012-11-21
Paris; FR
Gedrukt / Gemaakt in
Gewicht: 0,336 kg
Taal: Engels
128,39 € (DE)
131,99 € (AT)
142,00 CHF (CH)
POD
XVIII, 90 p.
BB; Oncology; Hardcover, Softcover / Medizin/Klinische Fächer; Onkologie; Verstehen; Biomedicine; Biosimilars; Cost; Immunogenicity; Interchangeability; Nephrology; Pharmacy; Pharmaceutical Sciences/Technology; Immunology; Oncology; Nephrology; Pharmacy; Pharmaceutics; Immunology; Nierenheilkunde, Nephrologie; Pharmazie, Apotheke; Medizinische Chemie, Pharmazeutische Chemie; Immunologie; BC; EA
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.Andere boeken die eventueel grote overeenkomsten met dit boek kunnen hebben:
Laatste soortgelijke boek:
9782817805146 Biosimilars (Jean-Louis Prugnaud; Jean-Hugues Trouvin)
< naar Archief...